Search

Search Constraints

You searched for: Author/Creator Kleinheinz, Tracy

Search Results

1. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity. (14th November 2019)

2. Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα). Issue 4 (15th February 2020)

3. Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927. Issue 16 (15th August 2019)

4. Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. (15th October 2021)

5. Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. Issue 4 (15th February 2019)

6. Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020). (13th January 2020)

7. Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. Issue 7 (1st April 2019)